Synapse - Daniel Danila

Search Within

Daniel C Danila

Results (42)

Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors

Journal Article

Mitsiades, N.; Sung, C. C.; Schultz, N.; Danila, D. C.; He, B.; Eedunuri, V. K.; Fleisher, M.; Sander, C.; Sawyers, C. L.; Scher, H. I.
Cancer Research (2012)

Fulltext@MSK | Save

The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)

Meeting Abstract

Danila, D.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
Annals of Oncology (2012)

Fulltext@MSK | Save

Evaluation of circulating tumor cell (CTC) enumeration as an efficacy response biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC): Planned final analysis (FA) of COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study of abiraterone acetate (AA) plus low-dose prednisone (P) post docetaxel

Meeting Abstract

Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T. S.; Attard, G.; Moreira, J.; Sandhu, S. K.; Parker, C.; Logothetis, C.; McCormack, R. T.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A six-gene panel that predicts survival in men with castration-resistant prostate cancer

Meeting Abstract

Subudhi, S. K.; Heller, G.; Anand, A.; Danila, D. C.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate

Journal Article

Danila, D. C.; Anand, A.; Sung, C. C.; Heller, G.; Leversha, M. A.; Cao, L.; Lilja, H.; Molina, A.; Sawyers, C. L.; Fleisher, M.; more...
European Urology (2011)

Fulltext@MSK | Save

A gene expression signature associated with sensitivity to the multikinase inhibitor dasatinib: Implications for development of a noninvasive biomarker for personalized therapy based on circulating tumor cell analysis

Meeting Abstract

Mitsiades, N.; Antipin, Y.; Reva, B.; Schultz, N.; Danila, D. C.; Sung, C. C.; Anand, A.; Sander, C.; Scher, H. I.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100

Meeting Abstract

Anand, A.; Scher, H. I.; Beer, T. M.; Higano, C. E.; Danila, D. C.; Taplin, M.; Efstathiou, E.; Hirmand, M.; Sawyers, C. L.; Heller, G.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer

Journal Article

Leversha, M. A.; Han, J.; Asgari, Z.; Danila, D. C.; Lin, O.; Gonzalez-Espinoza, R.; Anand, A.; Lilja, H.; Heller, G.; Fleisher, M.; more...
Clinical Cancer Research (2009)

Fulltext@MSK | Save

Circulating tumor cells in patients with castration-resistant metastatic prostate cancer

Meeting Abstract

Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer

Meeting Abstract

Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save